1. Home
  2. PCG vs KVUE Comparison

PCG vs KVUE Comparison

Compare PCG & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacific Gas & Electric Co.

PCG

Pacific Gas & Electric Co.

N/A

Current Price

$13.01

Market Cap

37.9B

Sector

Utilities

ML Signal

N/A

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$19.36

Market Cap

34.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCG
KVUE
Founded
1995
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Specialty Chemicals
Sector
Utilities
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
37.9B
34.2B
IPO Year
2001
2023

Fundamental Metrics

Financial Performance
Metric
PCG
KVUE
Price
$13.01
$19.36
Analyst Decision
Buy
Hold
Analyst Count
18
14
Target Price
$17.62
★ $19.50
AVG Volume (30 Days)
★ 30.7M
21.3M
Earning Date
10-22-2026
10-30-2026
Dividend Yield
1.51%
★ 4.35%
EPS Growth
2.61
★ 40.74
EPS
★ 0.72
0.71
Revenue
★ $24,935,000,000.00
$15,124,000,000.00
Revenue This Year
$3.81
$3.20
Revenue Next Year
$4.14
$2.38
P/E Ratio
★ $18.61
$27.27
Revenue Growth
★ 2.11
N/A
52 Week Low
$11.77
$15.94
52 Week High
$19.16
$20.13

Technical Indicators

Market Signals
Indicator
PCG
KVUE
Relative Strength Index (RSI) 45.82 61.77
Support Level $12.54 $18.67
Resistance Level $13.53 $20.02
Average True Range (ATR) 0.33 0.37
MACD 0.06 0.09
Stochastic Oscillator 42.34 73.98

Price Performance

Historical Comparison
PCG
KVUE

About PCG Pacific Gas & Electric Co.

PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.7 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: